BPIFA1: A Potential Drug Target Or Biomarker (G51297)

Target Name: BPIFA1

NCBI ID: G51297

BPIFA1: A Potential Drug Target Or Biomarker

BPIFA1, or BPI fold containing family A member 1, is a protein that is expressed in various tissues throughout the body. It is a member of the BPI (Bicistamial Pore) family, which is characterized by the presence of a bicistamial pore in the cytoplasm of the cell. This protein is of particular interest as a potential drug target or biomarker due to its unique structure and the involvement it plays in various physiological processes.

The BPI family is characterized by the presence of a bicistamial pore, which is a channel-like structure that is present in the cytoplasm of the cell. This pore is thought to play a role in the transfer of various molecules, including small molecules, ions, and water molecules, within the cell. The BPI family is composed of a variety of different proteins, each with a unique structure and function.

One of the proteins in the BPI family is BPIFA1. This protein is a member of the family A, which includes a number of different proteins that share a common structure and function. BPIFA1 is characterized by its ability to form a bicistamial pore in the cytoplasm of the cell. This pore allows the protein to participate in a variety of cellular processes, including the transport of molecules within the cell.

BPIFA1 is expressed in a variety of tissues throughout the body, including the brain, heart, and kidneys. It is also involved in several physiological processes, including the regulation of ion and water transport within the body. For example, studies have shown that BPIFA1 is involved in the regulation of the movement of ions and water into and out of the cells, which is important for maintaining the proper balance of these molecules within the body.

In addition to its role in ion and water transport, BPIFA1 is also involved in several other cellular processes. For example, it has been shown to play a role in the regulation of the formation of new blood vessels, which is important for maintaining blood flow to the body's tissues. It is also involved in the regulation of the movement of cells within the body, which is important for maintaining the proper structure and function of the body's tissues.

The potential drug target or biomarker properties of BPIFA1 are due to its unique structure and the involvement it plays in various physiological processes. The bicistamial pore in the cytoplasm of the cell, as well as its involvement in the regulation of ion and water transport, make it an attractive target for drug development. Additionally, the protein's expression in various tissues throughout the body also adds to its potential as a biomarker.

BPIFA1 has also been shown to play a role in several diseases, including cancer. Studies have shown that BPIFA1 is often overexpressed in various types of cancer, which may contribute to the development and progression of these diseases. Additionally, the protein's involvement in the regulation of blood vessels and cell movement also adds to its potential as a drug target or biomarker in these diseases.

In conclusion, BPIFA1 is a protein that is expressed in various tissues throughout the body and is involved in several physiological processes. Its unique structure, including the bicistamial pore in the cytoplasm of the cell, makes it an attractive target for drug development. Additionally, its involvement in various diseases, including cancer, makes it a potential biomarker for these diseases. Further research is needed to fully understand the role of BPIFA1 in these processes and its potential as a drug target or biomarker.

Protein Name: BPI Fold Containing Family A Member 1

Functions: Lipid-binding protein which shows high specificity for the surfactant phospholipid dipalmitoylphosphatidylcholine (DPPC) (PubMed:25223608). Plays a role in the innate immune responses of the upper airways (PubMed:23499554, PubMed:23132494). Reduces the surface tension in secretions from airway epithelia and inhibits the formation of biofilm by pathogenic Gram-negative bacteria, such as P.aeruginosa and K.pneumoniae (PubMed:23499554, PubMed:23132494, PubMed:27145151). Negatively regulates proteolytic cleavage of SCNN1G, an event that is required for activation of the epithelial sodium channel (ENaC), and thereby contributes to airway surface liquid homeostasis and proper clearance of mucus (PubMed:24124190, PubMed:24043776). Plays a role in the airway inflammatory response after exposure to irritants (PubMed:11425234). May attract macrophages and neutrophils (PubMed:23132494)

More Common Targets